Fernway, a leading cannabis brand in the Northeastern U.S., has announced strong financial results for Q2 2024 and significant strategic transactions that highlight its rapid growth and market expansion.

PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) announced on Thursday financial results for the fourth quarter and year ended December 31, 2023, as well as for the first quarter ended March 31, 2024.The Canadian parent of Colombia's cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., also said that effective July 3, 2024, its principal regulator, the Ontario Securities Commission has revoked its failure to file a cease trade order that was issued on May 7, 2024, due to the delay in filing its audited annual consolidated financial statements for the year ended December 31, 2023.

Canadian company The Good Shroom Co Inc. (TSTX:MUSH) announced its financial results for the quarter that ended on April 30, 2024....

Despite showing a decrease of 26% Year-Over-Year for Q3, the company highlighted the fact that it is its Tenth Consecutive Positive Quarter

Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now!

The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to recent financial data from Beacon Securities, the analysis of key financial metrics such as EV/EBITDA and P/CFO ratios reveals crucial insights.

Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced on Friday its financial results for the third quarter of fiscal year 2024 ended April 30, 2024. Michael Mills, the company's CEO, said BaM is working on streamlining its operations. "We continue to execute our strategy of reducing our footprint and focusing on developing our most valuable assets," he said in a press release. Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced on Friday its financial results for the third quarter of fiscal year 2024 ended April 30, 2024. Michael Mills, the company's CEO, said BaM is working on streamlining its operations. "We continue to execute our strategy of reducing our footprint and focusing on developing our most valuable assets," he said in a press release. In Illinois, the company's Markham-based dispensary shows signs of growth, while the building project in the Lynwood store is in its final stages, the company said.